{"id":1304,"date":"2023-12-05T14:11:31","date_gmt":"2023-12-05T06:11:31","guid":{"rendered":"https:\/\/cloone.my\/demo\/ijn2\/?page_id=1304"},"modified":"2023-12-29T15:35:32","modified_gmt":"2023-12-29T07:35:32","slug":"performance-report","status":"publish","type":"page","link":"https:\/\/cloone.my\/demo\/ijn2\/performance-report\/","title":{"rendered":"Performance Report"},"content":{"rendered":"

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1701070189557{padding-top: 50px !important;}” z_index=””][vc_column][vc_column_text]<\/p>\n

PERFORMANCE REPORT<\/span><\/h2>\n

[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1701237000636{padding-top: 50px !important;padding-bottom: 30px !important;background-color: #ecf5f9 !important;}” z_index=””][vc_column][vc_tabs style=”horizontal”][vc_tab title=”Validate Data” tab_id=”1701756758162-2-1″][vc_empty_space height=”20px”][vc_column_text]<\/p>\n

Clinical Outcomes<\/span><\/strong><\/h3>\n

[\/vc_column_text][vc_empty_space height=”20px”]

\n\t

\n\n\t \n Overview 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
\n
\n
\n\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>
\n\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>[vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

\n\n\t \n Cardiothoracic Surgeries <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
\n
\n [vc_column_text css=”.vc_custom_1701761059421{padding-top: 10px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #ffffff !important;}”]<\/p>\n\n\n\n\n\n\n\n\n\n
Coronary Artery Bypass Grafting (CABG)<\/td>\n1,489<\/td>\n<\/tr>\n
Valve Surgery<\/td>\n398<\/td>\n<\/tr>\n
Valve + CABG (Combined)<\/td>\n178<\/td>\n<\/tr>\n
Aortic Surgery (Vascular surgery)<\/td>\n418<\/td>\n<\/tr>\n
Congenital Heart Surgery Simple & Complex<\/td>\n716<\/td>\n<\/tr>\n
Thoracic Surgery<\/td>\n204<\/td>\n<\/tr>\n
Specialty Cases + Others<\/td>\n1,044<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

\n\n\t \n General Cardiology Procedures <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
\n
\n [vc_column_text css=”.vc_custom_1701761279145{padding-top: 10px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #ffffff !important;}”]<\/p>\n\n\n\n\n\n\n
Diagnostic Procedures<\/td>\n9,962<\/td>\n<\/tr>\n
Interventional Procedures<\/td>\n4,249<\/td>\n<\/tr>\n
Electrophysiology<\/td>\n1,536<\/td>\n<\/tr>\n
Implant Procedures<\/td>\n842<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div><\/div>[vc_empty_space height=”40px”][vc_column_text]<\/p>\n

Surgical Overview<\/span><\/strong><\/h3>\n

[\/vc_column_text][vc_empty_space height=”20px”]

\n\t

\n\n\t \n Total Volume Of Cardiothoracic Surgeries 2020 (N=4,161), 2021 (N=3,991) & 2022 (N=4,447) <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
\n
\n [vc_column_text]\"\"<\/p>\n

In 2022, IJN surgeons performed a total of 4,447 cardiothoracic surgeries including:<\/p>\n

    \n
  • Coronary Artery Bypass Grafting (CABG)<\/li>\n
  • Congenital Heart Surgery<\/li>\n
  • Heart valve repair and replacement<\/li>\n<\/ul>\n

    [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

    \n\n\t \n Open And Closed Heart Surgeries <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
    \n
    \n [vc_column_text]\"\"<\/p>\n

    In 2022, IJN surgeons performed 2,886 open heart surgeries and 1,241 closed heart surgeries:<\/p>\n

      \n
    • Open Heart: CABG, Congenital Heart surgery, Heart valve repair and replacement, Aortic root surgery<\/li>\n
    • Closed Heart: Thoracic surgery, Vascular surgery, Patent Ductus Arteriosus (PDA) ligation, Blalock Taussig (BT) Shunt, Coarctation repair<\/li>\n<\/ul>\n

      [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Cardiothoracic Surgeries By Category <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]\"\"[\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Risk Factors For Cardiac Surgeries (N = 6,105), 2020 \u2013 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]\"\"<\/p>\n

      Patients with a complex medical background present greater challenges for cardiac surgery. Almost half the patients had diabetes mellitus at time of surgery, and more than two thirds had hypertension and hypercholesterolemia.<\/p>\n

       <\/p>\n

      \n

      In 2022, patients who have had cardiac surgeries had more complex backgrounds than patients at comparable hospitals as evidenced by higher EuroSCORE \u2013 Parsonnet average risk scores.<\/p>\n<\/div>\n

      [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Actual And Predicted Survival Rates For All Types Of Open Heart Surgeries <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]<\/p>\n

      All operations<\/strong><\/h4>\n

      The survival rate for all open heart surgery was 94.4 % in 2022, which is better than the predicted survival rate estimated by the Parsonnet scoring system.<\/p>\n

       <\/p>\n

      Isolated Coronary Artery Bypass Grafting (CABG)<\/strong><\/h4>\n

      The survival rate for isolated CABG surgery was 96.1% in 2022, which is within the range of the predicted survival rate estimated by the EuroSCORE scoring system.[\/vc_column_text][vc_empty_space height=”20px”]

      \n\t
      \n\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>[vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Mortality Rate For Isolated Mitral Valve Repair, 2020 -2022 (Total No. Of Isolated Mitral Valve Repair Patient, N = 136) <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]Mitral Valve Repair is preferred over valve replacement whenever suitable. We report that there was no death (mortality) for patients undergoing mitral valve repair from 2020 to 2022.[\/vc_column_text][vc_empty_space height=”20px”]
      \n\t
      \n\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>[vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Mortality Rate For Ventricular Septal Defect (VSD) and Related Procedures, 2020 \u2013 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]\"\"<\/p>\n

      VSD Closure is the commonest surgery for acyanotic congenital heart defects. The death (mortality) rate for simple VSD closure is 0% in 2022..<\/p>\n

       <\/p>\n

      Total Number of Procedure:<\/strong><\/p>\n\n\n\n\n
      No.<\/span>
      \n<\/strong><\/td>\n      		Procedure<\/span>
      \n<\/strong><\/td>\n      		2020<\/span>
      \n<\/strong><\/td>\n      		2021<\/span>
      \n<\/strong><\/td>\n      		2022<\/span>
      \n<\/strong><\/td>\n<\/tr>\n
      1.<\/td>\nVSD Closure<\/td>\n230<\/td>\n229<\/td>\n249<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

      [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Mortality Rate For Tetralogy Of Fallot (TOF) Correction And Related Procedures, 2020 \u2013 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]\"\"<\/p>\n

      TOF correction is the most common surgery performed for cyanotic congenital heart defects. The death (mortality) rate for simple TOF correction is 1.1% in 2022.<\/p>\n

       <\/p>\n

      Total Number of Procedure:<\/strong><\/p>\n\n\n\n\n\n\n
      No.<\/span>
      \n<\/strong><\/td>\n      		Procedure<\/span>
      \n<\/strong><\/td>\n      		2020<\/span>
      \n<\/strong><\/td>\n      		2021<\/span>
      \n<\/strong><\/td>\n      		2022<\/span>
      \n<\/strong><\/td>\n<\/tr>\n
      1.<\/td>\nTOF Correction (Pulmonary Valve Preserved)<\/td>\n91<\/td>\n39<\/td>\n31<\/td>\n<\/tr>\n
      2.<\/td>\nTOF Correction \u00b1 Transannular Patch + Monocusp Valve<\/td>\n25<\/td>\n44<\/td>\n59<\/td>\n<\/tr>\n
      Total<\/span>
      \n<\/strong><\/td>\n      		116<\/span>
      \n<\/strong><\/td>\n      		83<\/span>
      \n<\/strong><\/td>\n      		90<\/span>
      \n<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

      [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div><\/div>[vc_empty_space height=”40px”][vc_column_text]<\/p>\n

      Ischemic Heart Disease \u2013 Interventional Treatment<\/span><\/strong><\/h3>\n

      [\/vc_column_text][vc_column_text]<\/p>\n

      IJN is the regional and national referral centre for percutaneous coronary intervention (PCI). A total of 15,231 cardiac catheterization procedures were performed in 2021 to treat patients with simple and complex ischemic heart disease.<\/h4>\n

      [\/vc_column_text][vc_empty_space height=”20px”]

      \n\t

      \n\n\t \n Use Of Appropriate Process Measures: Medications (N = 4,747), 2020 \u2013 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]\"\"<\/p>\n

      One of the key performance measures is the use of appropriate medications before and after PCI.<\/p>\n

       <\/p>\n

      From year 2020 to 2022, IJN achieved 98% use for all medication categories, which is comparable with ACC-National Cardiovascular Data Registry (NCDR).[\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n PCI Procedure, In-Hospital Mortality (PCI Procedure N = 3,702) 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]\"\"<\/p>\n

      The rate of in-hospital mortality among patients who had PCI procedures at IJN in 2022 is lower compared with ACC- National Cardiovascular Data Registry (NCDR).[\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Door-To-Balloon Time (N=1,574) 2018-2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]\"\"<\/p>\n

      IJN continues to improve door-to-balloon time to reduce the risk of mortality and morbidity, well below the target of 90 minutes for emergency treatment of Acute Myocardial Infarction or heart attacks. (American College of Cardiology\/American Heart Association (ACC\/AHA) guidelines for PCI inflation).<\/p>\n

       <\/p>\n

      IJN median door-to-balloon time was 50 minutes in 2022.[\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Cardiac Catheterization Procedures \u2013 Use Of Radial Access (N= 19,608), 2020 \u2013 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]\"\"<\/p>\n

      In 2022, IJN performed more cardiac catheterization procedures using radial access than other comparable hospitals (n= 7550)..<\/p>\n

       <\/p>\n

      \n

      The use of radial access is associated with reduction in bleeding complications, readmission rates, infection, and recovery time compared with PCI procedures done using a femoral approach.<\/p>\n<\/div>\n

      [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div><\/div>[vc_empty_space height=”40px”][vc_column_text]<\/p>\n

      Congenital Heart Disease<\/span><\/strong><\/h3>\n

      [\/vc_column_text][vc_empty_space height=”20px”]

      \n\t

      \n\n\t \n Total Volume Of Transcatheter (Non-Surgical) Procedures (N=2060), 2020 To 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]A total of 802 patients<\/strong> had transcatheter (non-surgical) procedures at IJN in 2022[\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Total Volume Of Interventional Procedures (N=980), 2020 To 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]In 2022, IJN performed 328 interventional procedures for paediatric and adult congenital heart disease patients. The top 6 interventional procedures are; ASD Occlusion, PDA Occlusion, PDA Stenting, Percutaneous Transluminal Balloon Valvuloplasty (PTBV), VSD Occlusion, and Right Ventricular Outflow Tract (RVOT) Stenting.<\/p>\n

       <\/p>\n\n\n\n\n\n\n\n\n\n\n\n
      No.<\/span>
      \n<\/strong><\/td>\n      		Procedure<\/span>
      \n<\/strong><\/td>\n      		Year<\/span>
      \n<\/strong><\/td>\n<\/tr>\n
      2020<\/span>
      \n<\/strong><\/td>\n      		2021<\/span>
      \n<\/strong><\/td>\n      		2022<\/span>
      \n<\/strong><\/td>\n<\/tr>\n
      1.<\/td>\nASD Occlusion<\/td>\n61<\/td>\n63<\/td>\n60<\/td>\n<\/tr>\n
      2.<\/td>\nPDA Occlusion<\/td>\n45<\/td>\n53<\/td>\n36<\/td>\n<\/tr>\n
      3.<\/td>\nPDA Stenting<\/td>\n46<\/td>\n40<\/td>\n25<\/td>\n<\/tr>\n
      4.<\/td>\nPercutaneous Transluminal Balloon Valvuloplasty (PTBV)<\/td>\n19<\/td>\n28<\/td>\n28<\/td>\n<\/tr>\n
      5.<\/td>\nVSD Occlusion<\/td>\n17<\/td>\n20<\/td>\n15<\/td>\n<\/tr>\n
      6.<\/td>\nRight Ventricular Outflow Tract (RVOT) Stenting<\/td>\n6<\/td>\n8<\/td>\n6<\/td>\n<\/tr>\n
      Total<\/span>
      \n<\/strong><\/td>\n      		194<\/span>
      \n<\/strong><\/td>\n      		212<\/span>
      \n<\/strong><\/td>\n      		170<\/span>
      \n<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

      [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

      \n\n\t \n Paediatric Cardiology Heart Surgery (N=3,744), 2020 \u2013 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
      \n
      \n [vc_column_text]\"\"<\/p>\n

      In 2022, IJN surgeons performed 1,251<\/strong> paediatric cardiac surgeries.<\/h4>\n

       <\/p>\n

      VSD<\/strong>\u00a0: Ventricular Septal Defect<\/p>\n

      TOF<\/strong>\u00a0: Tetralogy of Fallot<\/p>\n

      ASD<\/strong>\u00a0: Atrial Septal Defect<\/p>\n

      AVSD<\/strong>: Atrioventricular Septal Defect<\/p>\n

       <\/p>\n

      Closed Heart:<\/strong><\/p>\n

        \n
      • Patent Ductus Arteriosus (PDA) Ligation<\/li>\n
      • Blalock Taussig (BT) Shunt<\/li>\n
      • Coarctation of the Aorta (CoA) Repair<\/li>\n
      • Pulmonary Artery (PA) Banding<\/li>\n
      • Permanent Pacemaker (PPM) Implantation<\/li>\n<\/ul>\n

        [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div>

        \n\n\t \n Average Length Of Stay For Surgical Procedures Of ASD, TOF And VSD, 2020 To 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
        \n
        \n [vc_column_text]\"\"<\/p>\n

        The hospital length of stay for ASD, TOF and VSD were divided into 3 categories:<\/p>\n

          \n
        • a) Pre-op stay<\/li>\n
        • b) ICU stay<\/li>\n
        • c) Post-op stay<\/li>\n<\/ul>\n

          [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div><\/div>[vc_empty_space height=”40px”][vc_column_text]<\/p>\n

          Length Of Stay<\/span><\/strong><\/h3>\n

          [\/vc_column_text][vc_empty_space height=”20px”]

          \n\t

          \n\n\t \n Average Length Of Stay For Surgical Procedures Of ASD, TOF And VSD, 2020 To 2022 <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
          \n
          \n [vc_column_text]\"\"<\/p>\n

          We at IJN would like our patients to get back on their feet and resume normal life as soon as possible. Therefore, it is our priority to rehabilitate patients and reduce the length of stay.<\/p>\n

          \n
          \n
            \n
          • CABG<\/strong> \u2013 Coronary Artery Bypass Graftin<\/li>\n
          • VSD<\/strong> \u2013 Ventricular Septal Defect<\/li>\n
          • CRTP\/D<\/strong> \u2013 Cardiac Resynchronization Therapy Pacemaker\/ Defibrillator<\/li>\n
          • PPM<\/strong> \u2013 Permanent Pacemaker<\/li>\n
          • PCI<\/strong> \u2013 Percutaneous Coronary Intervention<\/li>\n
          • ICD<\/strong> \u2013 Implantable Cardioverter Defibrillator<\/li>\n<\/ul>\n<\/div>\n<\/div>\n

            [\/vc_column_text][vc_separator type=”normal” color=”#eaeaea” thickness=”1″ up=”20″] <\/div>\n<\/div><\/div>[\/vc_tab][vc_tab title=”Patient Experience” tab_id=”1701768316246-3-1″][vc_empty_space height=”20px”][vc_column_text]<\/p>\n

            Patient Experience<\/span><\/strong><\/h3>\n

            [\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]<\/p>\n

            Your experience at IJN is highly important to us and we continually strive to meet your needs and expectations. Your valuable feedback on our Patient Experience Surveys will help us further improve our services. We identified the results of our Patient Experience Survey based on the response from patients and family members who rated their overall experience in IJN as \u2018Excellent\u2019, \u2018Very Good\u2019 & \u2018Good\u2019.<\/h4>\n

            [\/vc_column_text][vc_empty_space height=”20px”][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner width=”1\/2″][vc_single_image image=”1336″ img_size=”full” alignment=”center” qode_css_animation=””][vc_empty_space height=”20px”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image image=”1335″ img_size=”full” alignment=”center” qode_css_animation=””][vc_empty_space height=”20px”][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=”Infection Prevention Program” tab_id=”1701768603297-2-2″][vc_empty_space height=”20px”][vc_column_text]<\/p>\n

            Infection Prevention & Control<\/span><\/strong><\/h3>\n

            [\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]<\/p>\n

            IJN\u2019s Infection Prevention Program is designed to improve the quality of care through the management of infection prevention, education and research. The Infection Control team collects data on hospital acquired infections and analyses the data to identify patterns and trends.<\/strong><\/h4>\n

            [\/vc_column_text][vc_empty_space height=”20px”][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1701769224961{border-bottom-width: 1px !important;padding-top: 20px !important;padding-bottom: 20px !important;border-bottom-color: #ffffff !important;border-bottom-style: solid !important;}”][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

            Hand Hygiene Compliance Rate<\/strong><\/span><\/h4>\n

             <\/p>\n

            The graph shows compliance rate by healthcare worker category that includes doctors, nurses and allied health personnel. The annual overall rate has shown a gradual improvement exceeding the Ministry of Health target of \u226575% compliance.<\/p>\n

             <\/p>\n

            IJN is committed to promoting hand hygiene practice at the point of care amongst our staff.[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image image=”1342″ img_size=”full” alignment=”center” qode_css_animation=””][vc_empty_space height=”20px”][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1701769224961{border-bottom-width: 1px !important;padding-top: 20px !important;padding-bottom: 20px !important;border-bottom-color: #ffffff !important;border-bottom-style: solid !important;}”][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

            Methicillin Resistant Staphylococcus Aureus (MRSA)<\/strong><\/span><\/h4>\n

             <\/p>\n

            MRSA is a type of bacteria that is resistant to several antibiotics and if left untreated, infections can become severe.<\/p>\n

             <\/p>\n

            In IJN, the MRSA incidence rate is 0.1% in year 2022.[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image image=”1341″ img_size=”full” alignment=”center” qode_css_animation=””][vc_empty_space height=”20px”][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1701769224961{border-bottom-width: 1px !important;padding-top: 20px !important;padding-bottom: 20px !important;border-bottom-color: #ffffff !important;border-bottom-style: solid !important;}”][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

            Catheter-related bloodstream infection (CRBSI)<\/strong><\/span><\/h4>\n

             <\/p>\n

            CRBSI is caused by bacteria originating from an intravenous catheter and is the most common cause of a hospital-acquired infection. A dedicated team educates staff and promotes best practices to reduce CRBSI.<\/p>\n

             <\/p>\n

            We calculate the total number of CRBSI cases against 1000 line-days. In 2022, the CRBSI rate was 4.0 per 1000 line-days.[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image image=”1340″ img_size=”full” alignment=”center” qode_css_animation=””][vc_empty_space height=”20px”][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1701769224961{border-bottom-width: 1px !important;padding-top: 20px !important;padding-bottom: 20px !important;border-bottom-color: #ffffff !important;border-bottom-style: solid !important;}”][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

            Ventilator Associated Pneumonia (VAP)
            \n<\/strong><\/span><\/h4>\n

             <\/p>\n

            VAP is defined as a hospital acquired pneumonia in a patient on mechanical ventilatory support (by endotracheal tube or tracheostomy).<\/p>\n

             <\/p>\n

            We calculate the VAP rate as total number of VAP cases against 1000 ventilator-days. In IJN, the VAP rate is 1.2 per 1000 ventilator-days in year 2022.<\/p>\n

             <\/p>\n

            NB: There is no minimum period of time that the ventilator must be in place in order for the pneumonia to be considered ventilator- associated.<\/em><\/strong>[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image image=”1339″ img_size=”full” alignment=”center” qode_css_animation=””][vc_empty_space height=”20px”][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1701769452519{padding-top: 20px !important;padding-bottom: 20px !important;}”][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

            Wound surveillance for Isolated CABG
            \n<\/strong><\/span><\/h4>\n

             <\/p>\n

            We monitor the rate of surgical site infection for isolated CABG based on the total number of cases with wound infection against the total number of patients who undergo CABG<\/p>\n

             <\/p>\n

            From January to September 2022, the average rate of surgical site infection was at 3.5%.[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image image=”1338″ img_size=”full” alignment=”center” qode_css_animation=””][vc_empty_space height=”20px”][\/vc_column_inner][\/vc_row_inner][\/vc_tab][\/vc_tabs][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

            [vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1701070189557{padding-top: 50px !important;}” z_index=””][vc_column][vc_column_text] PERFORMANCE REPORT [\/vc_column_text][vc_empty_space height=”20px”][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1701237000636{padding-top: 50px !important;padding-bottom: 30px !important;background-color: #ecf5f9 !important;}” z_index=””][vc_column][vc_tabs style=”horizontal”][vc_tab title=”Validate Data” tab_id=”1701756758162-2-1″][vc_empty_space height=”20px”][vc_column_text] Clinical Outcomes [\/vc_column_text][vc_empty_space height=”20px”][vc_empty_space height=”40px”][vc_column_text] Surgical Overview [\/vc_column_text][vc_empty_space height=”20px”][vc_empty_space…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"footnotes":""},"class_list":["post-1304","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cloone.my\/demo\/ijn2\/wp-json\/wp\/v2\/pages\/1304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloone.my\/demo\/ijn2\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cloone.my\/demo\/ijn2\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cloone.my\/demo\/ijn2\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cloone.my\/demo\/ijn2\/wp-json\/wp\/v2\/comments?post=1304"}],"version-history":[{"count":9,"href":"https:\/\/cloone.my\/demo\/ijn2\/wp-json\/wp\/v2\/pages\/1304\/revisions"}],"predecessor-version":[{"id":2247,"href":"https:\/\/cloone.my\/demo\/ijn2\/wp-json\/wp\/v2\/pages\/1304\/revisions\/2247"}],"wp:attachment":[{"href":"https:\/\/cloone.my\/demo\/ijn2\/wp-json\/wp\/v2\/media?parent=1304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}